HomeLEXX • NASDAQ
add
Lexaria Bioscience Corp
Previous close
$1.12
Day range
$1.06 - $1.13
Year range
$0.77 - $2.54
Market cap
23.56M USD
Avg Volume
187.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Aug 2025info | Y/Y change |
|---|---|---|
Revenue | 174.00K | 107.14% |
Operating expense | 2.65M | 15.82% |
Net income | -2.70M | -23.39% |
Net profit margin | -1.55K | 40.43% |
Earnings per share | — | — |
EBITDA | -2.45M | -12.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Aug 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.97M | -69.99% |
Total assets | 4.18M | -52.92% |
Total liabilities | 1.57M | 30.08% |
Total equity | 2.60M | — |
Shares outstanding | 22.23M | — |
Price to book | 7.47 | — |
Return on assets | -113.35% | — |
Return on capital | -154.77% | — |
Cash Flow
Net change in cash
| (USD) | Aug 2025info | Y/Y change |
|---|---|---|
Net income | -2.70M | -23.39% |
Cash from operations | -2.64M | -39.69% |
Cash from investing | -157.88K | -126.88% |
Cash from financing | 0.00 | — |
Net change in cash | -2.79M | -42.39% |
Free cash flow | -1.72M | -51.70% |
About
Founded
2004
Website
Employees
7
